Citigroup Portfolio holdings
Citigroup Inc., formed in 1998 through the landmark merger of Citicorp and Travelers Group, with roots tracing back to the 1812 founding of City Bank of New York, is a global financial powerhouse headquartered in New York City, managing trillions in assets. Operating in over 160 countries, Citigroup offers a broad spectrum of services, including consumer banking (via Citibank), investment banking, wealth management, and trading, serving millions of retail customers and major corporations, governments, and institutions worldwide. Under CEO Jane Fraser since 2021—the first woman to lead a major U.S. bank—Citigroup has focused on streamlining operations, exiting consumer banking in 13 markets to bolster its institutional and wealth management focus, while navigating post-2008 regulatory scrutiny and fines. Known for its vast global footprint and resilience through crises, Citigroup remains a key player in international finance, blending retail accessibility with high-stakes capital markets expertise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Russell 2000 ETF
IWM
|
+$860M |
| 2 |
ETP
Energy Transfer Partners, L.P.
ETP
|
+$277M |
| 3 |
JD.com
JD
|
+$232M |
| 4 |
Fortive
FTV
|
+$225M |
| 5 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$195M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1B |
| 2 |
iShares Core S&P 500 ETF
IVV
|
+$408M |
| 3 |
Apple
AAPL
|
+$394M |
| 4 |
Vanguard S&P 500 ETF
VOO
|
+$358M |
| 5 |
Invesco QQQ Trust
QQQ
|
+$301M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 5.1% |
| 2 | Financials | 4.96% |
| 3 | Consumer Discretionary | 3.91% |
| 4 | Healthcare | 3.67% |
| 5 | Industrials | 2.92% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
5751
Floor & Decor
FND
$6.13B
| $107K | ﹤0.01% |
3,538
+1,525
| +76% | +$62.2K |
|
5752
iShares US Broker-Dealers & Securities Exchanges ETF
IAI
$1.36B
| $107K | ﹤0.01% |
1,715
+201
| +13% | +$13.1K |
|
5753
Limoneira
LMNR
$235M
| $107K | ﹤0.01% |
4,095
+1,847
| +82% | +$51.3K |
|
|
DSKE
5754
DELISTED
Daseke, Inc. Common Stock
DSKE
| $107K | ﹤0.01% |
13,391
+2,708
| +25% | +$24.2K |
|
|
WPG
5755
CALL
DELISTED
Washington Prime Group Inc.
WPG
| $107K | ﹤0.01% |
1,633
+777
| +91% | +$53.8K |
|
5756
CALL
Arbutus Biopharma
ABUS
$857M
| $106K | ﹤0.01% |
11,200
+8,600
| +331% | +$85.4K |
|
|
AXDX
5757
PUT
DELISTED
Accelerate Diagnostics
AXDX
| $106K | ﹤0.01% |
460
-2,740
| -86% | -$606K |
|
5758
Teucrium Sugar Fund
CANE
$74.6M
| $106K | ﹤0.01% |
16,000
+3,000
| +23% | +$20.7K |
|
5759
BlackRock Enhanced Captial and Income Fund
CII
$988M
| $106K | ﹤0.01% |
6,185
+4,277
| +224% | +$72.4K |
|
5760
Liquidity Services
LQDT
$1.22B
| $106K | ﹤0.01% |
16,669
+10,437
| +167% | +$71.9K |
|
5761
Invesco S&P 500 BuyWrite ETF
PBP
$354M
| $106K | ﹤0.01% |
4,670
-1,837
| -28% | -$41.1K |
|
5762
iShares AAA-A Rated Corporate Bond ETF
QLTA
$1.24B
| $106K | ﹤0.01% |
2,100
-400
| -16% | -$20.2K |
|
|
TGNA
5763
PUT
DELISTED
TEGNA Inc
TGNA
| $106K | ﹤0.01% |
8,900
-5,700
| -39% | -$64.7K |
|
|
THQ
5764
abrdn Healthcare Opportunities Fund
THQ
$777M
| $106K | ﹤0.01% |
5,650
| – | – |
|
|
TAHO
5765
PUT
DELISTED
Tahoe Resources Inc
TAHO
| $106K | ﹤0.01% |
38,300
+13,400
| +54% | +$51.9K |
|
|
YELL
5766
DELISTED
Yellow Corporation Common Stock
YELL
| $106K | ﹤0.01% |
11,729
-7,506
| -39% | -$72.8K |
|
5767
PUT
Coca-Cola Europacific Partners
CCEP
$48.3B
| $105K | ﹤0.01% |
2,300
-25,800
| -92% | -$1.1M |
|
5768
Cytosorbents Corp
CTSO
$22.7M
| $105K | ﹤0.01% |
8,173
+4,096
| +100% | +$51.4K |
|
5769
Farmers & Merchants Bancorp
FMAO
$459M
| $105K | ﹤0.01% |
2,455
+1,242
| +102% | +$55.1K |
|
5770
Greenlight Captial
GLRE
$552M
| $105K | ﹤0.01% |
8,410
+6,714
| +396% | +$88.7K |
|
5771
Mistras Group
MG
$484M
| $105K | ﹤0.01% |
4,832
-1,211
| -20% | -$26.2K |
|
5772
Nordic American Tanker
NAT
$1.38B
| $105K | ﹤0.01% |
50,316
+14,085
| +39% | +$32.4K |
|
5773
Minerva Neurosciences
NERV
$185M
| $105K | ﹤0.01% |
1,047
+398
| +61% | +$29.9K |
|
5774
Omnicell
OMCL
$1.61B
| $105K | ﹤0.01% |
1,466
-11,019
| -88% | -$694K |
|
5775
PUT
Perdoceo Education
PRDO
$1.99B
| $105K | ﹤0.01% |
7,000
-2,800
| -29% | -$46.2K |
|
Similar funds
Citigroup's Q3 2018 Portfolio in Review
As of Q3 2018, Citigroup held 8,061 positions worth $112B, up 3% from $109B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Citigroup's Q3 2018 filing shows 419 new, 3,968 increased, 2,814 reduced and 254 closed positions. Its largest new stake was Invesco DWA NASDAQ Momentum ETF: 250,000 shares worth $29.3M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $1B.
By sector, the portfolio is most concentrated in Technology at 5.1% of assets, up from 5% a quarter earlier, followed by Financials and Consumer Discretionary.
- Citigroup's largest Q3 2018 buy was Invesco DWA NASDAQ Momentum ETF: 250,000 shares worth $29.3M.
- Citigroup added most to iShares Russell 2000 ETF in Q3 2018, an estimated $860M increase.
- Citigroup's biggest Q3 2018 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1B.
- Citigroup fully exited GGP Inc. in Q3 2018, selling an estimated $163M.
- Citigroup's ten largest holdings make up 22% of its $112B portfolio in Q3 2018.
- Citigroup opened 419 new positions and closed 254 in Q3 2018.
- Citigroup's portfolio value rose 3% quarter-over-quarter to $112B.
Based on Citigroup's 13F filing for Q3 2018, filed 13 Nov 2018.